read
interest
recent
paper
journal
luzatti
colleagu
explor
signific
presenc
herp
simplex
viru
hsv
dna
lower
respiratori
tract
lrt
specimen
diagnosi
hsv
pneumonia
immunocompromis
patient
author
underlin
difficulti
gaug
clinic
relev
laboratori
find
absenc
histopatholog
data
hsv
shed
lrt
may
occur
absenc
diseas
interpret
realtim
pcr
result
diagnosi
pneumocysti
jirovecii
pj
pneumonia
pjp
face
analog
challeng
sinc
presenc
pj
dna
lrt
may
reflect
colon
carriag
rather
infect
limit
inform
clinic
valu
pj
realtim
pcr
diagnos
pjp
patient
hematolog
diseas
exceedingli
challeng
sensit
direct
examin
procedur
suboptim
due
low
fungal
burden
report
experi
matter
total
episod
pneumonia
occur
consecut
patient
hematolog
disord
pjp
consid
differenti
etiolog
diagnosi
includ
episod
develop
patient
undergo
either
allogen
hematopoiet
stem
cell
transplantationallohsct
n
autologoushsct
n
nontranspl
patient
acut
leukemia
n
lymphoma
n
chronic
leukemia
n
other
n
patient
attend
hospit
universitariohcu
n
hospit
universitario
la
fe
hlf
n
june
august
patient
cohort
test
posit
hiv
studi
approv
respect
hospit
ethic
committe
inform
consent
obtain
patient
singl
specimen
per
episod
avail
diagnosi
bal
fluid
n
sputa
n
ta
n
bronchial
biopsi
n
realcycl
pjir
kit
r
progeni
molecular
spain
use
hcu
pneumocysti
jirovecii
real
time
pcr
detect
certest
biotech
zaragoza
spain
employ
hlf
see
footnot
tabl
assay
target
larg
subunit
ribosom
mtlsu
rna
gene
preliminari
experi
use
bal
specimen
indic
assay
yield
compar
pcr
cycl
threshold
c
median
rang
vs
median
rang
respect
p
specimen
test
neg
direct
examin
pj
wherea
posit
realtim
pcr
bal
n
sputa
n
ta
n
follow
stringent
clinic
microbiolog
imag
criteria
tabl
pjp
deem
probabl
diagnosi
episod
occur
uniqu
patient
histopatholog
confirm
pjp
avail
patient
pcr
c
valu
invers
correl
fungal
burden
sampl
higher
patient
pjp
colon
individu
overal
pj
pcr
c
specimen
patient
pjp
tend
lower
pj
carrier
p
bal
fluid
specimen
consid
differ
reach
statist
signific
median
rang
vs
median
rang
p
find
like
relat
use
standard
procedur
bal
fluid
sampl
receiv
oper
characterist
roc
curv
analysi
show
threshold
c
valu
bal
specimen
display
sensit
ci
specif
ci
pjp
diagnosi
number
studi
establish
differ
c
cutoff
purpos
view
howev
variabl
perform
differ
pcr
assay
sampl
condit
heterogen
patient
popul
particular
lack
pj
intern
standard
materi
pcr
result
normal
preclud
defin
consensu
univers
threshold
nowaday
absenc
antipj
prophylaxi
treatment
corticosteroid
serum
ldh
level
ul
shown
associ
pjp
patient
undergo
antipj
prophylaxi
like
display
clinic
signific
pj
pcr
result
tabl
turn
roc
curv
analysi
indic
cutoff
ldh
valu
ul
sensit
ci
specif
ci
pjp
diagnosi
univari
regress
logist
model
serum
ldh
valu
ul
associ
clinic
signific
posit
pcr
pj
result
ci
p
contrast
corticosteroid
use
within
month
sampl
differ
patient
clinic
signific
pj
detect
pj
carrier
tabl
detect
recoveri
microbi
agent
one
document
specimen
test
posit
pj
pcr
tabl
line
previou
report
microbiolog
find
significantli
less
frequent
p
specimen
patient
pjp
colon
patient
fact
microbi
codetect
invers
associ
pjp
univari
logist
regress
model
ci
p
strength
current
studi
follow
clinic
categor
pjp
base
upon
stringent
criteria
defin
multidisciplinari
team
ii
hematolog
patient
includ
iii
comprehens
routin
investig
microbi
caus
pneumonia
pj
conduct
iv
experi
two
center
collect
addit
retrospect
natur
studi
also
limit
complet
rule
patient
categor
pj
carrier
probabl
pneumocysti
jirovecii
pj
pneumonia
pjp
patient
retrospect
evalu
expert
committe
includ
infecti
diseas
microbiolog
specialist
center
basi
document
pj
presenc
respiratori
specimen
microscopi
ii
compat
clinic
sign
symptom
least
follow
subtl
onset
progress
dyspnea
pyrexia
nonproduct
cough
hypoxaemia
chest
pain
iii
compat
suggest
radiolog
find
chest
radiograph
andor
highresolut
comput
tomograph
scan
detect
interstiti
opac
andor
diffus
infiltr
infiltr
iv
complet
resolut
symptom
full
cours
antipjp
treatment
v
absenc
altern
diagnosi
efficaci
therapi
assess
daili
basi
pjp
rule
realtim
pcr
pj
test
neg
clinic
recoveri
occur
absenc
pjtarget
antimicrobi
therapi
pj
colon
carriag
like
possibl
patient
meet
criteria
altern
diagnosi
made
b
frequenc
compar
use
test
fisher
exact
test
categor
variabl
twosid
exact
p
valu
report
p
valu
consid
statist
signific
data
analyz
spss
version
statist
packag
c
respiratori
tract
specimen
obtain
follow
convent
procedur
specimen
examin
presenc
ascu
trophic
form
pj
microscopi
follow
blue
toluidin
calcofluor
white
grocott
methenamin
silver
stain
cytospin
prepar
prepar
bal
specimen
direct
examin
sputa
ta
sampl
mix
vv
sputasol
oxoid
uk
vortex
min
sampl
centrifug
g
min
pellet
resuspend
nacl
process
realtim
pcr
dna
extract
specimen
use
qiaamp
dna
blood
mini
kit
qiagen
hilden
germani
either
qia
symphoni
platform
qiagen
follow
manufactur
instruct
hcu
commerciallyavail
realtim
pcr
assay
previous
evalu
other
realcycl
pjir
kit
r
progeni
molecular
spain
target
mitochondri
larg
subunit
ribosom
mtlsu
rna
gene
use
accord
manufactur
instruct
http
wwwprogeniemolecularcompjiruinpdf
hlf
commerciallyavail
pneumocysti
jirovecii
real
time
pcr
detect
certest
biotech
zaragoza
spain
also
target
larg
subunit
ribosom
mtlsu
rna
gene
employ
follow
manufactur
instruct
http
wwwcertest
real
time
pcr
pneumocysti
jirovecii
center
pcr
perform
appli
biosystem
fast
realtim
pcr
platform
appli
biosystem
ca
usa
pcr
result
report
posit
neg
posit
sampl
threshold
cycl
c
valu
also
record
standard
curv
gener
posit
control
quantit
estim
antimicrobi
prophylaxi
pjp
perform
trimethoprimsulfamethoxazol
tmpsmx
one
doublestrength
tablet
mg
mg
smx
given
allogen
hsct
patient
time
week
oral
folic
acid
patient
suspicion
pjp
accord
attend
physician
treat
tmpsmx
mgkg
tmp
mgkg
smx
per
day
week
e
case
death
attribut
pjp
fact
pjp
patient
receiv
full
cours
tmpsmx
combin
antimicrobi
target
microbi
agent
lack
standard
criteria
pjp
diagnosi
make
clinic
misclassif
patient
potenti
drawback
studi
particularli
posit
microscopi
histopatholog
find
avail
ii
although
evalu
patient
presumpt
pjp
iii
two
differ
commerciallyavail
pcr
assay
use
across
center
nevertheless
found
yield
rather
compar
c
summari
found
posit
pj
pcr
result
respiratori
specimen
transplant
nontranspl
hematolog
patient
pneumonia
frequent
reflect
colon
rather
bal
bronchoalveolar
lavag
pjp
pneumocysi
jirovecii
pneumonia
ta
tracheal
aspir
per
routin
protocol
specimen
examin
gram
acidfast
bacilli
stain
sampl
also
examin
presenc
respiratori
virus
rv
use
either
luminex
xtag
rvp
fast
assay
luminex
molecular
diagnost
austin
tx
usa
hcu
pneumovir
assay
genomica
coslada
spain
center
previous
report
semiquantit
sputa
quantit
bal
ta
cultur
bacteria
perform
convent
media
bacteri
load
cfuml
cfuml
deem
clinic
relev
bal
fluid
ta
sampl
respect
specimen
cultur
bcyealpha
agar
bd
becton
dickinson
mycobacteria
growth
indic
tube
lowensteinjensen
agar
slant
sabouraud
agar
recoveri
legionella
pneumophila
mycobacterium
spp
fungal
organ
respect
platelia
tm
aspergillu
ag
kit
biorad
hercul
ca
usa
use
quantit
aspergillu
spp
galactomannan
bal
fluid
serum
specimen
bal
fluid
specimen
underw
cytomegaloviru
cmv
pcr
test
use
realtim
cmv
pcr
assay
abbott
molecular
hcu
cmv
assay
biomerieux
hlf
previous
report
conflict
interest
declar
